Identification of Type 1 Inosine Monophosphate Dehydrogenase as an Antiangiogenic Drug Target

doi 10.1021/jm051225t.s001
Full Text
Abstract

Available in full text

Date

Unknown

Authors

Unknown

Publisher

American Chemical Society (ACS)

Related search

Characterization of the Human Inosine-5′-Monophosphate Dehydrogenase Type II Gene

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

Overexpression of Inosine 5′-Monophosphate Dehydrogenase Type II Mediates Chemoresistance to Human Osteosarcoma Cells

PLoS ONE
Multidisciplinary
2010English

Inosine Monophosphate Dehydrogenase Activity in Renal Allograft Recipients During Mycophenolate Treatment

Scandinavian Journal of Clinical and Laboratory Investigation
MedicineClinical Biochemistry
2006English

The CBS Subdomain of Inosine 5′-Monophosphate Dehydrogenase Regulates Purine Nucleotide Turnover

Molecular Microbiology
MicrobiologyMolecular Biology
2008English

Recipient Pretransplant Inosine Monophosphate Dehydrogenase Activity in Nonmyeloablative Hematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Isolation and Characterization of Mycophenolic Acid-Resistant Mutants of Inosine-5′-Monophosphate Dehydrogenase

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1997English

Fragment-Based Approach to Targeting Inosine-5-Monophosphate Dehydrogenase (IMPDH) From Mycobacterium Tuberculosis

English

Antiviral Activities of Mizoribine and Other Inosine Monophosphate Dehydrogenase Inhibitors Against Several Ortho- And Paramyxoviruses

Antiviral Chemistry and Chemotherapy
MedicineVirologyDrug DiscoveryPharmacology
1994English

Experimental Characterization of Two Archaeal Inosine 5'-Monophosphate Cyclohydrolases

PLoS ONE
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy